AO "URALBIOFARM", Sverdlovsk Oblast

Accounting reports

Previously








Share:
Name
AKTSIONERNOE OBSCHESTVO "URALBIOFARM"
INN
6661000152
KPP
668501001
OGRN
1026605613396
OKPO
5766117
FFSM
31978-D
Address
620026, SVERDLOVSKAYA OBLAST', Ekaterinburg, ul. Kuybysheva, str. 60
Phone
+7 (343) 254-01-42  Contact details
Fax
+7 (343) 254-01-93

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
AO "URALBIOFARM" according to EGRUL

OKVED codeTypeName of activity type
21.10Core activityManufacture of manmade fibres
21.20.1Additional activity Production of drugs
46.18.9Additional activity Agents of goods in wholesale trade, not included in other categories
All types of activities
46.46.1Additional activityWholesale of furniture, carpets and lighting equipment
47.91Additional activityMail order and Internet retailers
49.4Additional activityFreight transport by road and removal services
52.10Additional activity Activity Warehousing and storage
52.24Additional activityCargo handling
73.20.1Additional activityMarket and opinion research
Registration date
02.10.2002
Registering department
Upravlenie gosudarstvennoy registratsii g. Ekaterinburga

AO "URALBIOFARM" (Sverdlovsk Oblast; INN 6661000152) was registered on 2 Oct 2002. The company's authorized capital as of July 1, 2012 was 200051913 rub.

Type of ownership of AO "URALBIOFARM" - Open joint-stock companies.

Form of ownership of AO "URALBIOFARM" - Private property.

Principal activities of AO "URALBIOFARM": manufacture of manmade fibres (21.10), production of drugs (21.20.1), agents of goods in wholesale trade, not included in other categories (46.18.9).

Economic indicators

2024

Net profit (RAS) of AO URALBIOFARM dropped in 2024 2.08 times to 84.58 million RUB from 176.09 million RUB over the same period in 2023, the company informed.

Revenue decreased in the accounting period by 22.96% to 1.32 billion RUB from 1.71 billion RUB in 2023; cost of goods sold decreased by 21.88% to 752.38 million RUB from 963.10 million RUB; sales profit fell 2.03 times to 217.63 million RUB from 441.15 million RUB.

2023

Net profit (RAS) of AO URALBIOFARM grew over 2023 1.66 times to 176.09 million RUB from 105.78 million RUB over 2022, the company informed.

Revenue increased in the accounting period by 33.83% to 1.71 billion RUB from 1.28 billion RUB over 2022; cost of goods sold grew by 24.89% to 963.10 million RUB from 771.13 million RUB; sales profit went up 1.87 times to 441.15 million RUB from 235.39 million RUB.

2022

Net profit (RAS) of URALBIOFARM, OAO grew over 2022 5.86 times to 105.78 million RUB from 18.05 million RUB over 2021, the company informed.

Revenue increased in the accounting period by 39.59% to 1.28 billion RUB from 917.24 million RUB over 2021; cost of goods sold grew by 24.63% to 771.13 million RUB from 618.73 million RUB; sales profit went up 3.70 times to 235.39 million RUB from 63.55 million RUB.

2021

Net profit (RAS) of URALBIOFARM, OAO grew over 2021 20.42 times to 18.05 million RUB from 884.00 thousand RUB over 2020, the company informed.

Revenue decreased in the accounting period by 13.07% to 917.24 million RUB from 1.06 billion RUB in 2020; cost of goods sold decreased by 7.60% to 618.73 million RUB from 669.65 million RUB; sales profit fell 2.52 times to 63.55 million RUB from 159.94 million RUB.

2020

Net profit (RAS) of URALBIOFARM, OAO dropped in 2020 7.01 times to 884.00 thousand RUB from 6.20 million RUB over the same period in 2019, the company informed.

Revenue increased in the accounting period by 47.97% to 1.06 billion RUB from 713.08 million RUB over 2019; cost of goods sold grew by 37.46% to 669.65 million RUB from 487.16 million RUB; sales profit made up 159.94 million RUB compared to sales loss of 3.88 million RUB.

2019

Net profit (RAS) of URALBIOFARM, OAO grew over 2019 by 12.08% to 6.20 million RUB from 5.53 million RUB over 2018, the company informed.

Revenue increased in the accounting period by 19.52% to 713.08 million RUB from 596.61 million RUB over 2018; cost of goods sold grew by 17.03% to 487.16 million RUB from 416.26 million RUB; sales loss decreased 6.32 times to 3.88 million RUB from 24.51 million RUB.

2018

Net profit (RAS) of URALBIOFARM, OAO grew over 2018 by 16.61% to 5.53 million RUB from 4.74 million RUB over 2017, the company informed.

Revenue decreased in the accounting period by 8.05% to 596.61 million RUB from 648.84 million RUB in 2017; cost of goods sold remained at the same level amounting to 416.26 million RUB compared to 414.88 million RUB; sales loss made up 24.51 million RUB compared to sales profit of 10.36 million RUB.

2017

Net profit (RAS) of URALBIOFARM, OAO dropped in 2017 13.94 times to 4.74 million RUB from 66.12 million RUB over the same period in 2016, the company informed.

Revenue decreased in the accounting period by 20.22% to 648.84 million RUB from 813.28 million RUB in 2016; cost of goods sold decreased by 23.75% to 414.88 million RUB from 544.09 million RUB; sales profit fell 5.20 times to 10.36 million RUB from 53.91 million RUB.

2016

Net profit (RAS) of URALBIOFARM, OAO grew over 2016 by 29.99% to 66.12 million RUB from 50.87 million RUB over 2015, the company informed.

Revenue increased in the accounting period by 2.78% to 813.28 million RUB from 791.26 million RUB over 2015; cost of goods sold grew by 0.93% to 544.09 million RUB from 539.08 million RUB; sales profit fell by 11.81% to 53.91 million RUB from 61.13 million RUB.

2014

Net profit (RAS) of URALBIOFARM, OAO grew over 2014 3.87 times to 87.64 million RUB from 22.64 million RUB over 2013, the company informed.

Revenue decreased in the accounting period by 6.55% to 558.01 million RUB from 597.14 million RUB in 2013; cost of goods sold decreased by 11.90% to 391.28 million RUB from 444.14 million RUB; sales profit matched the previous year’s result amounting to 37.65 million RUB.

2013

Net profit (RAS) of Uralbiofarm, OAO grew over 2013 by 34.62% to 22.64 million RUB from 16.82 million RUB over 2012, the company informed.

Revenue decreased in the accounting period by 19.24% to 597.14 million RUB from 739.44 million RUB in 2012; cost of goods sold decreased by 23.03% to 444.14 million RUB from 577.02 million RUB; sales profit fell by 32.09% to 37.76 million RUB from 55.60 million RUB.

2012

Net profit (RAS) of Uralbiofarm, OAO grew over 2012 1.95 times to 16.82 million RUB from 8.65 million RUB over 2011, the company informed.

Cost of goods sold decreased by 10.74% to 577.02 million RUB from 646.42 million RUB; sales profit went up by 32.12% to 55.60 million RUB from 42.08 million RUB.




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 463 577
Reports
17 430 541
Rrocessed requests
Extract from EGRUL:
Today, 7:30 PM
Accounting reports:
Today, 7:31 PM
The site can contain materials of 16+ category
info@k-agent.ru
Рейтинг@Mail.ru
© "Info-RL", 2006—2025
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru